Intraosseous Infusion of Unrelated Cord Blood Grafts

Key facts

Sponsor

Emory University

Principal Investigator

John Horan, MD

Emory University

Intervention

cord blood infusion(procedure)

Enrollment

5 enrolled

Eligibility

60 years · All sexes

Timeline

2007 – 2011

Study locations (2)

• Children's Healthcare of Atlanta, Atlanta, Georgia, United States
• Emory University, Atlanta, Georgia, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute undifferentiated leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT06466395
  A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
  M.D. Anderson Cancer Center

See all trials for Acute undifferentiated leukemia →